Markets:

Overview

News

Currencies

International

Treasuries

Pyxis Oncology, Inc. - Common Stock (NQ:PYXS)

1.845 +0.135 (+7.89%)

Streaming Delayed Price Updated: 10:37 AM EDT, Apr 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Pyxis Oncology, Inc. - Common Stock

< Previous 1 2 3 Next >

Curious about the stocks that are showing activity after the closing bell on Friday? ↗

January 09, 2026

Via Chartmill

Unusual volume stocks in Tuesday's session ↗

December 23, 2025

Let's explore the current happenings on the US markets on Tuesday. Below, you'll find the stocks exhibiting unusual volume in today's session.

Via Chartmill

Top movers in Thursday's session ↗

December 18, 2025

Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Keep an eye on the top gainers and losers in Thursday's session. ↗

December 18, 2025

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.

Via Chartmill

Pyxis Oncology: Q4 Earnings Insights ↗

March 21, 2024

Via Benzinga

There are notable gap-ups and gap-downs in today's session. ↗

December 18, 2025

In today's session, there are notable price gaps in the US markets on Thursday. Take a closer look at the stocks that are gap up and gap down.

Via Chartmill

Discover the top movers in Thursday's pre-market session. ↗

December 18, 2025

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Via Chartmill

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 06, 2025

Via Benzinga

Pyxis Oncology's Deprioritizes Second Pipeline Asset, Analyst Applauds Move ↗

December 20, 2024

Pyxis Oncology prioritizes PYX-201 with promising Phase 1 results in solid tumors, while deprioritizing PYX-106 due to resource allocation and challenges.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 21, 2024

Via Benzinga

Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results ↗

November 21, 2024

Via Benzinga

Crude Oil Gains 1%; Deere Posts Better-Than-Expected Earnings ↗

November 21, 2024

Via Benzinga

Dow Jumps Over 100 Points; Nvidia Posts Upbeat Earnings ↗

November 21, 2024

Via Benzinga

Topics Stocks

Pyxis Oncology's Cancer Drug Progress Stirs Analyst Concerns ↗

November 21, 2024

Pyxis Oncology announces mixed Phase 1 PYX-201 data, collaboration with Merck, and analyst downgrade citing limited efficacy beyond head-and-neck cancer.

Via Benzinga

Pyxis Oncology's Cancer Drug Platform Shows Potential, Analyst Sees Over 190% Upside ↗

November 08, 2024

Stephens initiates coverage on Pyxis Oncology (PYXS), highlighting its promising ADC technology and a $13 price target, with upcoming clinical trial results.

Via Benzinga

PYXS Stock Earnings: Pyxis Oncology Misses EPS for Q2 2024 ↗

August 14, 2024

PYXS stock results show that Pyxis Oncology missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

PYXS Stock Earnings: Pyxis Oncology Beats EPS, Beats Revenue for Q1 2024 ↗

May 14, 2024

PYXS stock results show that Pyxis Oncology beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday ↗

April 03, 2024

U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday.

Via Benzinga

Topics Stocks

Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 03, 2024

Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly...

Via Benzinga

3 Biotech Stocks to Buy on the Dip: March 2024 ↗

March 27, 2024

Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three.

Via InvestorPlace

Why FedEx Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗

March 22, 2024

Shares of FedEx Corporation (NYSE: FDX) rose sharply in today’s pre-market trading after the company reported better-than-expected earnings for its third quarter and authorized a new $5 billion

Via Benzinga

Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 21, 2024

Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-than-expected second-quarter revenue and issued FY24 guidance.

Via Benzinga

PYXS Stock Earnings: Pyxis Oncology Beats EPS for Q4 2023 ↗

March 21, 2024

PYXS stock results show that Pyxis Oncology beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires ↗

March 19, 2024

These biotech stocks to buy offer a gateway to long-term gains, on the back of groundbreaking healthcare innovations.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

March 15, 2024

It's time to start the final day of trading this week with a look into the biggest pre-market stock movers for Friday morning!

Via InvestorPlace

3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024 ↗

February 22, 2024

With new innovation and high demand, biotech stocks could offer some of the most explosive opportunities of the year.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 29, 2023

Via Benzinga

Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 27, 2024

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

Via Benzinga

Pyxis Oncology M&A Spotlight Signals Potential Growth Amidst Competitive ADC Landscape: Analyst ↗

September 05, 2023

RBC Capital Markets has initiated coverage on Pyxis Oncology Inc (NASDAQ: PYXS) with an Outperform rating and a

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023 ↗

September 05, 2023

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.